An enzyme immunoassay screening test for the detection of total antinuclear antibodies
- 1 January 1991
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 5 (6) , 439-442
- https://doi.org/10.1002/jcla.1860050612
Abstract
The enzyme immunoassay antinuclear antibody (EIA ANA) screening test method is a new assay format for the qualitative determination of antinuclear antibodies (ANAs) in human serum or plasma. This assay method collectively detects ANAs against double stranded DNA (dsDNA), SS‐A/Ro, SS‐B/La, Scl‐70, Sm, and Sm/RNP antigens, along with serum positive for peripheral, homogeneous, speckled, nucleolar, and centromere patterns. This assay correlated well with data obtained with hemagglutination tests for specific ANA antigens, with the indirect immunofluorescence (IFA) ANA HEp‐2 test, and with the Crithidia luciliae IFA test for antidsDNA. This new test procedure is both highly specific and sensitive and substantially decreases the time involved when screening large numbers of patient samples.Keywords
This publication has 7 references indexed in Scilit:
- Immunoglobulin Class and Subclass Profile of the Ro/SS-A Autoantibody ResponseJournal of Investigative Dermatology, 1988
- Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies.Journal of Clinical Investigation, 1985
- A simple, rapid ELISA method for the detection of DNA antibodies.Journal of Clinical Pathology, 1982
- Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and MedicinePublished by Elsevier ,1982
- Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapyJournal of Clinical Investigation, 1971
- The clinical significance of titered antinuclear antibodiesArthritis & Rheumatism, 1967
- Antinuclear antibodies: Diagnostic significance and methodsArthritis & Rheumatism, 1967